-
1
-
-
80755125565
-
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
-
Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29: 1039-1045
-
(2011)
Nat Biotechnol
, vol.29
, pp. 1039-1045
-
-
Anastassiadis, T.1
Deacon, S.W.2
Devarajan, K.3
Ma, H.4
Peterson, J.R.5
-
2
-
-
77957055294
-
Synthetic lethal screen of an EGFRcentered network to improve targeted therapies
-
Astsaturov I, Ratushny V, Sukhanova A, Einarson MB, Bagnyukova T, Zhou Y, Devarajan K, Silverman JS, Tikhmyanova N, Skobeleva N, Pecherskaya A, Nasto RE, Sharma C, Jablonski SA, Serebriiskii IG, Weiner LM, Golemis EA (2010) Synthetic lethal screen of an EGFRcentered network to improve targeted therapies. Sci Signal 3: ra67
-
(2010)
Sci Signal
, vol.3
, pp. 67
-
-
Astsaturov, I.1
Ratushny, V.2
Sukhanova, A.3
Einarson, M.B.4
Bagnyukova, T.5
Zhou, Y.6
Devarajan, K.7
Silverman, J.S.8
Tikhmyanova, N.9
Skobeleva, N.10
Pecherskaya, A.11
Nasto, R.E.12
Sharma, C.13
Jablonski, S.A.14
Serebriiskii, I.G.15
Weiner, L.M.16
Golemis, E.A.17
-
3
-
-
38049150665
-
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
-
Bean J, Brennan C, Shih JY, Riely G, Viale A, Wang L, Chitale D, Motoi N, Szoke J, Broderick S, Balak M, Chang WC, Yu CJ, Gazdar A, Pass H, Rusch V, Gerald W, Huang SF, Yang PC, Miller V et al (2007) MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci USA 104: 20932-20937
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 20932-20937
-
-
Bean, J.1
Brennan, C.2
Shih, J.Y.3
Riely, G.4
Viale, A.5
Wang, L.6
Chitale, D.7
Motoi, N.8
Szoke, J.9
Broderick, S.10
Balak, M.11
Chang, W.C.12
Yu, C.J.13
Gazdar, A.14
Pass, H.15
Rusch, V.16
Gerald, W.17
Huang, S.F.18
Yang, P.C.19
Miller, V.20
more..
-
4
-
-
78649973178
-
Inhibition of, ALK PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene
-
Chen Z, Sasaki T, Tan X, Carretero J, Shimamura T, Li D, Xu C,Wang Y, Adelmant GO, Capelletti M, Lee HJ, Rodig SJ, Borgman C, Park SI, Kim HR, Padera R, Marto JA, Gray NS, Kung AL, Shapiro GI et al (2010) Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene. Cancer Res 70: 9827-9836
-
(2010)
Cancer Res
, vol.70
, pp. 9827-9836
-
-
Chen, Z.1
Sasaki, T.2
Tan, X.3
Carretero, J.4
Shimamura, T.5
Li, D.6
Xu, C.7
Wang, Y.8
Adelmant, G.O.9
Capelletti, M.10
Lee, H.J.11
Rodig, S.J.12
Borgman, C.13
Park, S.I.14
Kim, H.R.15
Padera, R.16
Marto, J.A.17
Gray, N.S.18
Kung, A.L.19
Shapiro, G.I.20
more..
-
5
-
-
80755125575
-
Comprehensive analysis of kinase inhibitor selectivity
-
Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol 29: 1046-1051
-
(2011)
Nat Biotechnol
, vol.29
, pp. 1046-1051
-
-
Davis, M.I.1
Hunt, J.P.2
Herrgard, S.3
Ciceri, P.4
Wodicka, L.M.5
Pallares, G.6
Hocker, M.7
Treiber, D.K.8
Zarrinkar, P.P.9
-
6
-
-
14844366111
-
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines
-
DOI 10.1073/pnas.0409773102
-
Engelman JA, Janne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C, Cichowski K, Johnson BE, Cantley LC (2005) ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci USA 102: 3788-3793 (Pubitemid 40354690)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.10
, pp. 3788-3793
-
-
Engelman, J.A.1
Janne, P.A.2
Mermel, C.3
Pearlberg, J.4
Mukohara, T.5
Fleet, C.6
Cichowski, K.7
Johnson, B.E.8
Cantley, L.C.9
-
7
-
-
34249075147
-
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
-
DOI 10.1126/science.1141478
-
Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, LindemanN, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Janne PA (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316: 1039-1043 (Pubitemid 46799492)
-
(2007)
Science
, vol.316
, Issue.5827
, pp. 1039-1043
-
-
Engelman, J.A.1
Zejnullahu, K.2
Mitsudomi, T.3
Song, Y.4
Hyland, C.5
Joon, O.P.6
Lindeman, N.7
Gale, C.-M.8
Zhao, X.9
Christensen, J.10
Kosaka, T.11
Holmes, A.J.12
Rogers, A.M.13
Cappuzzo, F.14
Mok, T.15
Lee, C.16
Johnson, B.E.17
Cantley, L.C.18
Janne, P.A.19
-
8
-
-
73349129405
-
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
-
Faber AC, Li D, Song Y, Liang MC, Yeap BY, Bronson RT, Lifshits E, Chen Z, Maira SM, Garcia-Echeverria C, Wong KK, Engelman JA (2009) Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition. Proc Natl Acad Sci USA 106: 19503-19508
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 19503-19508
-
-
Faber, A.C.1
Li, D.2
Song, Y.3
Liang, M.C.4
Yeap, B.Y.5
Bronson, R.T.6
Lifshits, E.7
Chen, Z.8
Maira, S.M.9
Garcia-Echeverria, C.10
Wong, K.K.11
Engelman, J.A.12
-
9
-
-
78049426367
-
Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3
-
Fischer T, Stone RM, Deangelo DJ, Galinsky I, Estey E, Lanza C, Fox E, Ehninger G, Feldman EJ, Schiller GJ, Klimek VM, Nimer SD, Gilliland DG, Dutreix C, Huntsman-Labed A, Virkus J, Giles FJ (2010) Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3. J Clin Oncol 28: 4339-4345
-
(2010)
J Clin Oncol
, vol.28
, pp. 4339-4345
-
-
Fischer, T.1
Stone, R.M.2
Deangelo, D.J.3
Galinsky, I.4
Estey, E.5
Lanza, C.6
Fox, E.7
Ehninger, G.8
Feldman, E.J.9
Schiller, G.J.10
Klimek, V.M.11
Nimer, S.D.12
Gilliland, D.G.13
Dutreix, C.14
Huntsman-Labed, A.15
Virkus, J.16
Giles, F.J.17
-
10
-
-
0037050026
-
Functional organization of the yeast proteome by systematic analysis of protein complexes
-
DOI 10.1038/415141a
-
Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM, Michon AM, Cruciat CM, Remor M, Hofert C, Schelder M, Brajenovic M, Ruffner H, Merino A, Klein K, Hudak M, Dickson D, Rudi Tet al (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415: 141-147 (Pubitemid 34059510)
-
(2002)
Nature
, vol.415
, Issue.6868
, pp. 141-147
-
-
Gavin, A.-C.1
Bosche, M.2
Krause, R.3
Grandi, P.4
Marzioch, M.5
Bauer, A.6
Schultz, J.7
Rick, J.M.8
Michon, A.-M.9
Cruciat, C.-M.10
Remor, M.11
Hofert, C.12
Schelder, M.13
Brajenovic, M.14
Ruffner, H.15
Merino, A.16
Klein, K.17
Hudak, M.18
Dickson, D.19
Rudi, T.20
Gnau, V.21
Bauch, A.22
Bastuck, S.23
Huhse, B.24
Leutwein, C.25
Heurtier, M.-A.26
Copley, R.R.27
Edelmann, A.28
Querfurth, E.29
Rybin, V.30
Drewes, G.31
Raida, M.32
Bouwmeester, T.33
Bork, P.34
Seraphin, B.35
Kuster, B.36
Neubauer, G.37
Superti-Furga, G.38
more..
-
11
-
-
58549085778
-
An integrated workflow for charting the human interaction proteome: Insights into the PP2A system
-
Glatter T, Wepf A, Aebersold R, Gstaiger M (2009) An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Mol Syst Biol 5: 237
-
(2009)
Mol Syst Biol
, vol.5
, pp. 237
-
-
Glatter, T.1
Wepf, A.2
Aebersold, R.3
Gstaiger, M.4
-
12
-
-
68949206409
-
Applying mass spectrometry-based proteomics to genetics, genomics and network biology
-
Gstaiger M, Aebersold R (2009) Applying mass spectrometry-based proteomics to genetics, genomics and network biology. Nat Rev Genet 10: 617-627
-
(2009)
Nat Rev Genet
, vol.10
, pp. 617-627
-
-
Gstaiger, M.1
Aebersold, R.2
-
13
-
-
79951544193
-
Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer
-
Haura EB, Muller A, Breitwieser FP, Li J, Grebien F, Colinge J, Bennett KL (2011) Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer. J Proteome Res 10: 182-190
-
(2011)
J Proteome Res
, vol.10
, pp. 182-190
-
-
Haura, E.B.1
Muller, A.2
Breitwieser, F.P.3
Li, J.4
Grebien, F.5
Colinge, J.6
Bennett, K.L.7
-
15
-
-
61449172037
-
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
-
Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57
-
(2009)
Nat Protoc
, vol.4
, pp. 44-57
-
-
Huang Da, W.1
Sherman, B.T.2
Lempicki, R.A.3
-
16
-
-
1942469322
-
Analysis of clathrin-Mediated endocytosis of epidermal growth factor receptor by RNA interference
-
DOI 10.1074/jbc.C400046200
-
Huang F, Khvorova A, Marshall W, Sorkin A (2004) Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J Biol Chem 279: 16657-16661 (Pubitemid 38509367)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.16
, pp. 16657-16661
-
-
Huang, F.1
Khvorova, A.2
Marshall, W.3
Sorkin, A.4
-
17
-
-
33746930864
-
A uniform proteomics MS/MS analysis platform utilizing open XML file formats
-
Keller A, Eng J, Zhang N, Li XJ, Aebersold R (2005) A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol Syst Biol 1: 2005 0017
-
(2005)
Mol Syst Biol
, vol.1
, pp. 20050017
-
-
Keller, A.1
Eng, J.2
Zhang, N.3
Li, X.J.4
Aebersold, R.5
-
18
-
-
78651287426
-
DrugBank 3.0: A comprehensive resource for 'omics' research on drugs
-
Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC,Wishart DS (2011) DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 39: D1035-D1041
-
(2011)
Nucleic Acids Res
, vol.39
, pp. 1035-1041
-
-
Knox, C.1
Law, V.2
Jewison, T.3
Liu, P.4
Ly, S.5
Frolkis, A.6
Pon, A.7
Banco, K.8
Mak, C.9
Neveu, V.10
Djoumbou, Y.11
Eisner, R.12
Guo, A.C.13
Wishart, D.S.14
-
19
-
-
3543046114
-
Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases
-
DOI 10.1074/jbc.M403759200
-
Kowanetz K, Crosetto N, Haglund K, Schmidt MH, Heldin CH, Dikic I (2004) Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J Biol Chem 279: 32786-32795 (Pubitemid 39014738)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.31
, pp. 32786-32795
-
-
Kowanetz, K.1
Crosetto, N.2
Haglund, K.3
Schmidt, M.H.H.4
Heldin, C.-H.5
Dikic, I.6
-
20
-
-
84873902360
-
Noncovalent wild-Type-Sparing inhibitors of EGFR T790M
-
Lee HJ, Schaefer G, Heffron TP, Shao L, Ye X, Sideris S, Malek S, Chan E, Merchant M, La H, Ubhayakar S, Yauch RL, Pirazzoli V, Politi K, Settleman J (2013) Noncovalent Wild-type-Sparing Inhibitors of EGFR T790M. Cancer Discov 3: 168-181
-
(2013)
Cancer Discov
, vol.3
, pp. 168-181
-
-
Lee, H.J.1
Schaefer, G.2
Heffron, T.P.3
Shao, L.4
Ye, X.5
Sideris, S.6
Malek, S.7
Chan, E.8
Merchant, M.9
La Ubhayakar H, S.10
Yauch, R.L.11
Pirazzoli, V.12
Politi, K.13
Settleman, J.14
-
21
-
-
77949848665
-
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
-
Li J, Rix U, Fang B, Bai Y, Edwards A, Colinge J, Bennett KL, Gao J, Song L, Eschrich S, Superti-Furga G, Koomen J, Haura EB (2010) A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol 6: 291-299
-
(2010)
Nat Chem Biol
, vol.6
, pp. 291-299
-
-
Li, J.1
Rix, U.2
Fang, B.3
Bai, Y.4
Edwards, A.5
Colinge, J.6
Bennett, K.L.7
Gao, J.8
Song, L.9
Eschrich, S.10
Superti-Furga, G.11
Koomen, J.12
Haura, E.B.13
-
22
-
-
33846108633
-
BindingDB: A web-accessible database of experimentally determined proteinligand binding affinities
-
Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined proteinligand binding affinities. Nucleic Acids Res 35: D198-D201
-
(2007)
Nucleic Acids Res
, vol.35
, pp. 198-201
-
-
Liu, T.1
Lin, Y.2
Wen, X.3
Jorissen, R.N.4
Gilson, M.K.5
-
23
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of Non-Small-Cell lung cancer to gefitinib
-
DOI 10.1056/NEJMoa040938
-
Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139 (Pubitemid 38637993)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.21
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
Gurubhagavatula, S.4
Okimoto, R.A.5
Brannigan, B.W.6
Harris, P.L.7
Haserlat, S.M.8
Supko, J.G.9
Haluska, F.G.10
Louis, D.N.11
Christiani, D.C.12
Settleman, J.13
Haber, D.A.14
-
24
-
-
78149463029
-
Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling
-
Machida K, Eschrich S, Li J, Bai Y, Koomen J, Mayer BJ, Haura EB (2010) Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling. PLoS One 5: e13470
-
(2010)
PLoS One
, vol.5
, pp. 13470
-
-
Machida, K.1
Eschrich, S.2
Li, J.3
Bai, Y.4
Koomen, J.5
Mayer, B.J.6
Haura, E.B.7
-
25
-
-
20844444589
-
Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor
-
DOI 10.1023/B:DRUG.0000047103.64335.b0
-
Marshall JL, Kindler H, Deeken J, Bhargava P, Vogelzang NJ, Rizvi N, Luhtala T, Boylan S, Dordal M, Robertson P, Hawkins MJ, Ratain MJ (2005) Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor. Invest New Drugs 23: 31-37 (Pubitemid 39505949)
-
(2005)
Investigational New Drugs
, vol.23
, Issue.1
, pp. 31-37
-
-
Marshall, J.L.1
Kindler, H.2
Deeken, J.3
Bhargava, P.4
Vogelzang, N.J.5
Rizvi, N.6
Luhtala, T.7
Boylan, S.8
Dordal, M.9
Robertson, P.10
Hawkins, M.J.11
Ratain, M.J.12
-
26
-
-
65949104526
-
Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors
-
McDermott U, Ames RY, Iafrate AJ, Maheswaran S, Stubbs H, Greninger P, McCutcheon K, Milano R, Tam A, Lee DY, Lucien L, Brannigan BW, Ulkus LE, Ma XJ, Erlander MG, Haber DA, Sharma SV, Settleman J (2009) Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors. Cancer Res 69: 3937-3946
-
(2009)
Cancer Res
, vol.69
, pp. 3937-3946
-
-
McDermott, U.1
Ames, R.Y.2
Iafrate, A.J.3
Maheswaran, S.4
Stubbs, H.5
Greninger, P.6
McCutcheon, K.7
Milano, R.8
Tam, A.9
Lee, D.Y.10
Lucien, L.11
Brannigan, B.W.12
Ulkus, L.E.13
Ma, X.J.14
Erlander, M.G.15
Haber, D.A.16
Sharma, S.V.17
Settleman, J.18
-
27
-
-
38049097938
-
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
-
McDermott U, Sharma SV, Dowell L, Greninger P, Montagut C, Lamb J, Archibald H, Raudales R, Tam A, Lee D, Rothenberg SM, Supko JG, Sordella R, Ulkus LE, Iafrate AJ, Maheswaran S, Njauw CN, Tsao H, Drew L, Hanke JH et al (2007) Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling. Proc Natl Acad Sci USA 104: 19936-19941
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 19936-19941
-
-
McDermott, U.1
Sharma, S.V.2
Dowell, L.3
Greninger, P.4
Montagut, C.5
Lamb, J.6
Archibald, H.7
Raudales, R.8
Tam, A.9
Lee, D.10
Rothenberg, S.M.11
Supko, J.G.12
Sordella, R.13
Ulkus, L.E.14
Iafrate, A.J.15
Maheswaran, S.16
Njauw, C.N.17
Tsao, H.18
Drew, L.19
Hanke, J.H.20
more..
-
28
-
-
1342310067
-
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer
-
DOI 10.1093/annonc/mdh052
-
Monnerat C, Henriksson R, Le Chevalier T, Novello S, Berthaud P, Faivre S, Raymond E (2004) Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with nonsmall-cell lung cancer. Ann Oncol 15: 316-323 (Pubitemid 38262634)
-
(2004)
Annals of Oncology
, vol.15
, Issue.2
, pp. 316-323
-
-
Monnerat, C.1
Henriksson, R.2
Le Chevalier, T.3
Novello, S.4
Berthaud, P.5
Faivre, S.6
Raymond, E.7
-
29
-
-
80054851888
-
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
-
Moulick K, Ahn JH, ZongH, RodinaA, Cerchietti L,Gomes DaGama EM, Caldas-Lopes E, Beebe K, Perna F,Hatzi K,Vu LP, Zhao X, ZatorskaD, Taldone T, Smith-Jones P, Alpaugh M, Gross SS, Pillarsetty N, Ku T, Lewis JS et al (2011) Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol 7: 818-826
-
(2011)
Nat Chem Biol
, vol.7
, pp. 818-826
-
-
Moulick, K.1
Ahn, J.H.2
Zong, H.3
Rodina, A.4
Cerchietti, L.5
Gomes Dagama, E.M.6
Caldas-Lopes, E.7
Beebe, K.8
Perna, F.9
Hatzi, K.10
Vu, L.P.11
Zhao, X.12
Zatorska, D.13
Taldone, T.14
Smith-Jones, P.15
Alpaugh, M.16
Gross, S.S.17
Pillarsetty, N.18
Ku, T.19
Lewis, J.S.20
more..
-
30
-
-
52749083383
-
Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: An analytical database
-
Murray S, Dahabreh IJ, Linardou H, Manoloukos M, Bafaloukos D, Kosmidis P (2008) Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical database. J Thorac Oncol 3: 832-839
-
(2008)
J Thorac Oncol
, vol.3
, pp. 832-839
-
-
Murray, S.1
Dahabreh, I.J.2
Linardou, H.3
Manoloukos, M.4
Bafaloukos, D.5
Kosmidis, P.6
-
31
-
-
84863895754
-
Chemical biology: Greasy tags for protein removal
-
Neklesa TK, Crews CM (2012) Chemical biology: Greasy tags for protein removal. Nature 487: 308-309
-
(2012)
Nature
, vol.487
, pp. 308-309
-
-
Neklesa, T.K.1
Crews, C.M.2
-
32
-
-
79960562309
-
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins
-
Neklesa TK, Tae HS, Schneekloth AR, Stulberg MJ, Corson TW, Sundberg TB, Raina K, Holley SA, Crews CM (2011) Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins. Nat Chem Biol 7: 538-543
-
(2011)
Nat Chem Biol
, vol.7
, pp. 538-543
-
-
Neklesa, T.K.1
Tae, H.S.2
Schneekloth, A.R.3
Stulberg, M.J.4
Corson, T.W.5
Sundberg, T.B.6
Raina, K.7
Holley, S.A.8
Crews, C.M.9
-
33
-
-
2342624080
-
EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy
-
DOI 10.1126/science.1099314
-
Paez JG, Ja?nne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500 (Pubitemid 38720929)
-
(2004)
Science
, vol.304
, Issue.5676
, pp. 1497-1500
-
-
Paez, J.G.1
Janne, P.A.2
Lee, J.C.3
Tracy, S.4
Greulich, H.5
Gabriel, S.6
Herman, P.7
Kaye, F.J.8
Lindeman, N.9
Boggon, T.J.10
Naoki, K.11
Sasaki, H.12
Fujii, Y.13
Eck, M.J.14
Sellers, W.R.15
Johnson, B.E.16
Meyerson, M.17
-
34
-
-
4444344330
-
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
-
DOI 10.1073/pnas.0405220101
-
Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H (2004) EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101: 13306-13311 (Pubitemid 39209661)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.36
, pp. 13306-13311
-
-
Pao, W.1
Miller, V.2
Zakowski, M.3
Doherty, J.4
Politi, K.5
Sarkaria, I.6
Singh, B.7
Heelan, R.8
Rusch, V.9
Fulton, L.10
Mardis, E.11
Kupfer, D.12
Wilson, R.13
Kris, M.14
Varmus, H.15
-
35
-
-
18244371651
-
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
-
Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, Kris MG, Varmus H (2005) Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2: 1-11
-
(2005)
PLoS Med
, vol.2
, pp. 1-11
-
-
Pao, W.1
Miller, V.A.2
Politi, K.A.3
Riely, G.J.4
Somwar, R.5
Zakowski, M.F.6
Kris, M.G.7
Varmus, H.8
-
37
-
-
34548683924
-
Suppressor of T-cell receptor signalling 1 and 2 differentially regulate endocytosis and signalling of receptor tyrosine kinases
-
DOI 10.1016/j.febslet.2007.08.077, PII S0014579307009647
-
Raguz J, Wagner S, Dikic I, Hoeller D (2007) Suppressor of T-cell receptor signalling 1 and 2 differentially regulate endocytosis and signalling of receptor tyrosine kinases. FEBS Lett 581: 4767-4772 (Pubitemid 47418806)
-
(2007)
FEBS Letters
, vol.581
, Issue.24
, pp. 4767-4772
-
-
Raguz, J.1
Wagner, S.2
Dikic, I.3
Hoeller, D.4
-
38
-
-
70349684791
-
Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer
-
Regales L, Gong Y, Shen R, de Stanchina E, Vivanco I, Goel A, Koutcher JA, SpassovaM, Ouerfelli O,Mellinghoff IK, Zakowski MF, Politi KA, Pao W (2009) Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer. J Clin Invest 119: 3000-3010
-
(2009)
J Clin Invest
, vol.119
, pp. 3000-3010
-
-
Regales, L.1
Gong, Y.2
Shen, R.3
De Stanchina, E.4
Vivanco, I.5
Goel, A.6
Koutcher, J.A.7
Spassovam8
Ouerfelli, O.9
Mellinghoff, I.K.10
Zakowski, M.F.11
Politi, K.A.12
Pao, W.13
-
39
-
-
61449164033
-
RNAither, an automated pipeline for the statistical analysis of high-throughput RNAi screens
-
Rieber N, Knapp B, Eils R, Kaderali L (2009) RNAither, an automated pipeline for the statistical analysis of high-throughput RNAi screens. Bioinformatics 25: 678-679
-
(2009)
Bioinformatics
, vol.25
, pp. 678-679
-
-
Rieber, N.1
Knapp, B.2
Eils, R.3
Kaderali, L.4
-
40
-
-
36849065315
-
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
-
DOI 10.1016/j.cell.2007.11.025, PII S009286740701522X
-
Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE et al (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203 (Pubitemid 350235027)
-
(2007)
Cell
, vol.131
, Issue.6
, pp. 1190-1203
-
-
Rikova, K.1
Guo, A.2
Zeng, Q.3
Possemato, A.4
Yu, J.5
Haack, H.6
Nardone, J.7
Lee, K.8
Reeves, C.9
Li, Y.10
Hu, Y.11
Tan, Z.12
Stokes, M.13
Sullivan, L.14
Mitchell, J.15
Wetzel, R.16
MacNeill, J.17
Ren, J.M.18
Yuan, J.19
Bakalarski, C.E.20
Villen, J.21
Kornhauser, J.M.22
Smith, B.23
Li, D.24
Zhou, X.25
Gygi, S.P.26
Gu, T.-L.27
Polakiewicz, R.D.28
Rush, J.29
Comb, M.J.30
more..
-
41
-
-
37049014938
-
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets
-
DOI 10.1182/blood-2007-07-102061
-
Rix U, Hantschel O, Durnberger G, Remsing Rix LL, Planyavsky M, Fernbach NV, Kaupe I, Bennett KL, Valent P, Colinge J, Kocher T, Superti-Furga G (2007) Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood 110: 4055-4063 (Pubitemid 350248462)
-
(2007)
Blood
, vol.110
, Issue.12
, pp. 4055-4063
-
-
Rix, U.1
Hantschel, O.2
Durnberger, G.3
Remsing Rix, L.L.4
Planyavsky, M.5
Fernbach, N.V.6
Kaupe, I.7
Bennett, K.L.8
Valent, P.9
Colinge, J.10
Kocher, T.11
Superti-Furga, G.12
-
42
-
-
69949186250
-
Screening for epidermal growth factor receptor mutations in lung cancer
-
Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larriba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N et al (2009) Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 361: 958-967
-
(2009)
N Engl J Med
, vol.361
, pp. 958-967
-
-
Rosell, R.1
Moran, T.2
Queralt, C.3
Porta, R.4
Cardenal, F.5
Camps, C.6
Majem, M.7
Lopez-Vivanco, G.8
Isla, D.9
Provencio, M.10
Insa, A.11
Massuti, B.12
Gonzalez-Larriba, J.L.13
Paz-Ares, L.14
Bover, I.15
Garcia-Campelo, R.16
Moreno, M.A.17
Catot, S.18
Rolfo, C.19
Reguart, N.20
more..
-
43
-
-
21144458164
-
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
-
DOI 10.1038/nbt1046
-
Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, Zhang H, Zha XM, Polakiewicz RD, Comb MJ (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23: 94-101 (Pubitemid 41724631)
-
(2005)
Nature Biotechnology
, vol.23
, Issue.1
, pp. 94-101
-
-
Rush, J.1
Moritz, A.2
Lee, K.A.3
Guo, A.4
Goss, V.L.5
Spek, E.J.6
Zhang, H.7
Zha, X.-M.8
Polakiewicz, R.D.9
Comb, M.J.10
-
44
-
-
77954584507
-
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: Results of a phase II trial in patients with advanced non-small-cell lung cancer
-
Sequist LV, Besse B, Lynch TJ, Miller VA,Wong KK, Gitlitz B, Eaton K, Zacharchuk C, Freyman A, Powell C, Ananthakrishnan R, Quinn S, Soria JC (2010a) Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer. J Clin Oncol 28: 3076-3083
-
(2010)
J Clin Oncol
, vol.28
, pp. 3076-3083
-
-
Sequist, L.V.1
Besse, B.2
Lynch, T.J.3
Miller, V.A.4
Wong, K.K.5
Gitlitz, B.6
Eaton, K.7
Zacharchuk, C.8
Freyman, A.9
Powell, C.10
Ananthakrishnan, R.11
Quinn, S.12
Soria, J.C.13
-
45
-
-
85015494145
-
Activity of IPI-504
-
Sequist LV, Gettinger S, SenzerNN,Martins RG, Janne PA, LilenbaumR, Gray JE, Iafrate AJ, Katayama R, Hafeez N, Sweeney J, Walker JR, Fritz C, Ross RW, Grayzel D, Engelman JA, Borger DR, Paez G, Natale R (2010b) Activity of IPI-504, a novel heat-shock protein 90
-
(2010)
A Novel Heat-shock Protein
, vol.90
-
-
Sequist, L.V.1
Gettinger, S.2
Senzer, N.N.3
Martins, R.G.4
Janne, P.A.5
Lilenbaum, R.6
Gray, J.E.7
Iafrate, A.J.8
Katayama, R.9
Hafeez, N.10
Sweeney, J.11
Walker, J.R.12
Fritz, C.13
Ross, R.W.14
Grayzel, D.15
Engelman, J.A.16
Borger, D.R.17
Paez, G.18
Natale, R.19
-
46
-
-
79951885125
-
Patients with molecularly defined non-small-cell lung cancer
-
inhibitor
-
inhibitor, in patients with molecularly defined non-small-cell lung cancer. J Clin Oncol 28: 4953-4960
-
J Clin Oncol
, vol.28
, pp. 4953-4960
-
-
-
47
-
-
79953118839
-
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
-
Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ et al (2011) Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 3: 75ra26
-
(2011)
Sci Transl Med
, vol.3
, pp. 75-26
-
-
Sequist, L.V.1
Waltman, B.A.2
Dias-Santagata, D.3
Digumarthy, S.4
Turke, A.B.5
Fidias, P.6
Bergethon, K.7
Shaw, A.T.8
Gettinger, S.9
Cosper, A.K.10
Akhavanfard, S.11
Heist, R.S.12
Temel, J.13
Christensen, J.G.14
Wain, J.C.15
Lynch, T.J.16
Vernovsky, K.17
Mark, E.J.18
Lanuti, M.19
Iafrate, A.J.20
more..
-
48
-
-
33750627972
-
A common signaling cascade may underlie addiction to the Src, BCR-ABL, and EGF receptor oncogenes
-
DOI 10.1016/j.ccr.2006.09.014, PII S1535610806002923
-
Sharma SV, Gajowniczek P,Way IP, Lee DY, Jiang J, Yuza Y, Classon M, Haber DA, Settleman J (2006) A common signaling cascade may underlie addiction to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell 10: 425-435 (Pubitemid 44693471)
-
(2006)
Cancer Cell
, vol.10
, Issue.5
, pp. 425-435
-
-
Sharma, S.V.1
Gajowniczek, P.2
Way, I.P.3
Lee, D.Y.4
Jiang, J.5
Yuza, Y.6
Classon, M.7
Haber, D.A.8
Settleman, J.9
-
49
-
-
44649083135
-
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
-
Shimamura T, Li D, Ji H, Haringsma HJ, Liniker E, Borgman CL, Lowell AM, Minami Y, McNamara K, Perera SA, Zaghlul S, Thomas RK, Greulich H, Kobayashi S, Chirieac LR, Padera RF, Kubo S, Takahashi M, Tenen DG, Meyerson M et al (2008) Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance. Cancer Res 68: 5827-5838
-
(2008)
Cancer Res
, vol.68
, pp. 5827-5838
-
-
Shimamura, T.1
Li, D.2
Ji, H.3
Haringsma, H.J.4
Liniker, E.5
Borgman, C.L.6
Lowell, A.M.7
Minami, Y.8
McNamara, K.9
Perera, S.A.10
Zaghlul, S.11
Thomas, R.K.12
Greulich, H.13
Kobayashi, S.14
Chirieac, L.R.15
Padera, R.F.16
Kubo, S.17
Takahashi, M.18
Tenen, D.G.19
Meyerson, M.20
more..
-
50
-
-
22244485706
-
Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins
-
DOI 10.1158/0008-5472.CAN-05-0933
-
Shimamura T, Lowell AM, Engelman JA, Shapiro GI (2005) Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Res 65: 6401-6408 (Pubitemid 40994428)
-
(2005)
Cancer Research
, vol.65
, Issue.14
, pp. 6401-6408
-
-
Shimamura, T.1
Lowell, A.M.2
Engelman, J.A.3
Shapiro, G.I.4
-
51
-
-
35549013373
-
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling
-
DOI 10.1038/sj.onc.1210503, PII 1210503
-
Shtiegman K, Kochupurakkal BS, Zwang Y, Pines G, Starr A, Vexler A, Citri A, Katz M, Lavi S, Ben-Basat Y, Benjamin S, Corso S, Gan J, Yosef RB, Giordano S, Yarden Y (2007) Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. Oncogene 26: 6968-6978 (Pubitemid 350014608)
-
(2007)
Oncogene
, vol.26
, Issue.49
, pp. 6968-6978
-
-
Shtiegman, K.1
Kochupurakkal, B.S.2
Zwang, Y.3
Pines, G.4
Starr, A.5
Vexler, A.6
Citri, A.7
Katz, M.8
Lavi, S.9
Ben-Basat, Y.10
Benjamin, S.11
Corso, S.12
Gan, J.13
Yosef, R.B.14
Giordano, S.15
Yarden, Y.16
-
52
-
-
70449433271
-
Oncogenemutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells
-
Soh J, Okumura N, Lockwood WW, Yamamoto H, Shigematsu H, ZhangW, Chari R, Shames DS, TangX,MacAulay C, Varella-GarciaM, Vooder T, Wistuba II, Lam S, Brekken R, Toyooka S, Minna JD, LamWL, Gazdar AF (2009) Oncogenemutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One 4: e7464
-
(2009)
PLoS One
, vol.4
, pp. 7464
-
-
Soh, J.1
Okumura, N.2
Lockwood, W.W.3
Yamamoto, H.4
Shigematsu, H.5
Zhang, W.6
Chari, R.7
Shames, D.S.8
Tang, X.9
Macaulay, C.10
Varella-Garcia, M.11
Vooder, T.12
Wistuba, I.I.13
Lam, S.14
Brekken, R.15
Toyooka, S.16
Minna, J.D.17
Lam, W.L.18
Gazdar, A.F.19
-
53
-
-
4143066760
-
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
-
DOI 10.1126/science.1101637
-
Sordella R, BellDW, Haber DA, Settleman J (2004) Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163-1167 (Pubitemid 39100331)
-
(2004)
Science
, vol.305
, Issue.5687
, pp. 1163-1167
-
-
Sordella, R.1
Bell, D.W.2
Haber, D.A.3
Settleman, J.4
-
54
-
-
76249108622
-
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation
-
Sos ML, Rode HB, Heynck S, Peifer M, Fischer F, Kluter S, Pawar VG, Reuter C, Heuckmann JM, Weiss J, Ruddigkeit L, Rabiller M, Koker M, Simard JR, Getlik M, Yuza Y, Chen TH, Greulich H, Thomas RK, Rauh D (2010) Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation. Cancer Res 70: 868-874
-
(2010)
Cancer Res
, vol.70
, pp. 868-874
-
-
Sos, M.L.1
Rode, H.B.2
Heynck, S.3
Peifer, M.4
Fischer, F.5
Kluter, S.6
Pawar, V.G.7
Reuter, C.8
Heuckmann, J.M.9
Weiss, J.10
Ruddigkeit, L.11
Rabiller, M.12
Koker, M.13
Simard, J.R.14
Getlik, M.15
Yuza, Y.16
Chen, T.H.17
Greulich, H.18
Thomas, R.K.19
Rauh, D.20
more..
-
55
-
-
0034720255
-
Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia
-
Stepanova L, YangG,DeMayo F,Wheeler TM, FinegoldM, Thompson TC, Harper JW (2000) Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia. Oncogene 19: 2186-2193 (Pubitemid 30307184)
-
(2000)
Oncogene
, vol.19
, Issue.18
, pp. 2186-2193
-
-
Stepanova, L.1
Yang, G.2
DeMayo, F.3
Wheeler, T.M.4
Finegold, M.5
Thompson, T.C.6
Harper, J.W.7
-
56
-
-
79959872399
-
Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib
-
Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T (2011) Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib. J Thorac Oncol 6: 1152-1161
-
(2011)
J Thorac Oncol
, vol.6
, pp. 1152-1161
-
-
Suda, K.1
Tomizawa, K.2
Fujii, M.3
Murakami, H.4
Osada, H.5
Maehara, Y.6
Yatabe, Y.7
Sekido, Y.8
Mitsudomi, T.9
-
57
-
-
79952292499
-
Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase
-
Sun T, Aceto N, Meerbrey KL, Kessler JD, Zhou C, Migliaccio I, Nguyen DX, Pavlova NN, Botero M, Huang J, Bernardi RJ, Schmitt E, Hu G, Li MZ, Dephoure N, Gygi SP, Rao M, Creighton CJ, Hilsenbeck SG, Shaw CA et al (2011) Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase. Cell 144: 703-718
-
(2011)
Cell
, vol.144
, pp. 703-718
-
-
Sun, T.1
Aceto, N.2
Meerbrey, K.L.3
Kessler, J.D.4
Zhou, C.5
Migliaccio, I.6
Nguyen, D.X.7
Pavlova, N.N.8
Botero, M.9
Huang, J.10
Bernardi, R.J.11
Schmitt, E.12
Hu, G.13
Li, M.Z.14
Dephoure, N.15
Gygi, S.P.16
Rao, M.17
Creighton, C.J.18
Hilsenbeck, S.G.19
Shaw, C.A.20
more..
-
58
-
-
84867760241
-
HER2 amplification: A potential mechanism of acquired resistance to EGFR inhibition in EGFR mutant lung cancers that lack the second-site EGFR T790M mutation
-
Takezawa K, PirazzoliV, ArcilaME, Nebhan CA, Song X, de Stanchina E, Ohashi K, Janjigian YY, Spitzler PJ, Melnick MA, Riely GJ, Kris MG, Miller VA, Ladanyi M, Politi K, Pao W (2012) HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR mutant lung cancers that lack the second-site EGFR T790M mutation. Cancer Discov 2: 922-933
-
Cancer Discov
, vol.2
, pp. 922-933
-
-
Takezawa, K.1
Pirazzoli, V.2
Arcila, M.E.3
Nebhan, C.A.4
Song, X.5
De Stanchina, E.6
Ohashi, K.7
Janjigian, Y.Y.8
Spitzler, P.J.9
Ma, M.10
Riely, G.J.11
Kris, M.G.12
Miller, V.A.13
Ladanyi, M.14
Politi, K.15
Pao, W.16
-
59
-
-
73449096114
-
Frequency of and variables associated with the EGFR mutation and its subtypes
-
Tanaka T, Matsuoka M, Sutani A, Gemma A, Maemondo M, Inoue A, Okinaga S, Nagashima M, Oizumi S, Uematsu K, Nagai Y, Moriyama G, Miyazawa H, Ikebuchi K, Morita S, Kobayashi K, Hagiwara K (2010) Frequency of and variables associated with the EGFR mutation and its subtypes. Int J Cancer 126: 651-655
-
(2010)
Int J Cancer
, vol.126
, pp. 651-655
-
-
Tanaka, T.1
Matsuoka, M.2
Sutani, A.3
Gemma, A.4
Maemondo, M.5
Inoue, A.6
Okinaga, S.7
Nagashima, M.8
Oizumi, S.9
Uematsu, K.10
Nagai, Y.11
Moriyama, G.12
Miyazawa, H.13
Ikebuchi, K.14
Morita, S.15
Kobayashi, K.16
Hagiwara, K.17
-
60
-
-
80053649037
-
Survival and death signals can predict tumor response to therapy after oncogene inactivation
-
Tran PT, Bendapudi PK, Lin HJ, Choi P, Koh S, Chen J, Horng G, Hughes NP, Schwartz LH, Miller VA, Kawashima T, Kitamura T, Paik D, Felsher DW (2011) Survival and death signals can predict tumor response to therapy after oncogene inactivation. Sci Transl Med 3: 103ra199
-
(2011)
Sci Transl Med
, vol.3
, pp. 103-199
-
-
Tran, P.T.1
Bendapudi, P.K.2
Lin, H.J.3
Choi, P.4
Koh, S.5
Chen, J.6
Horng, G.7
Hughes, N.P.8
Schwartz, L.H.9
Miller, V.A.10
Kawashima, T.11
Kitamura, T.12
Paik, D.13
Felsher, D.W.14
-
61
-
-
61849159164
-
PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders
-
Veillette A, Rhee I, Souza CM, Davidson D (2009) PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders. Immunol Rev 228: 312-324
-
(2009)
Immunol Rev
, vol.228
, pp. 312-324
-
-
Veillette, A.1
Rhee, I.2
Souza, C.M.3
Davidson, D.4
-
62
-
-
79959453191
-
BindingDB and ChEMBL: Online compound databases for drug discovery
-
Wassermann AM, Bajorath J (2011) BindingDB and ChEMBL: online compound databases for drug discovery. Expert Opin Drug Discov 6: 683-687
-
(2011)
Expert Opin Drug Discov
, vol.6
, pp. 683-687
-
-
Wassermann, A.M.1
Bajorath, J.2
-
63
-
-
10444288735
-
TIM, a Dbl-related protein, regulates cell shape and cytoskeletal organization in a Rho-dependent manner
-
DOI 10.1016/j.cellsig.2004.09.012, PII S0898656804002001
-
Xie X, Chang SW, Tatsumoto T, Chan AM, Miki T (2005) TIM, a Dbl-related protein, regulates cell shape and cytoskeletal organization in a Rho-dependent manner. Cell Signal 17: 461-471 (Pubitemid 39643064)
-
(2005)
Cellular Signalling
, vol.17
, Issue.4
, pp. 461-471
-
-
Xie, X.1
Chang, S.W.2
Tatsumoto, T.3
Chan, A.M.L.4
Miki, T.5
-
64
-
-
77954212739
-
Targeting epidermal growth factor receptor: Central signaling kinase in lung cancer
-
Yoshida T, Zhang G, Haura EB (2010) Targeting epidermal growth factor receptor: central signaling kinase in lung cancer. Biochem Pharmacol 80: 613-623
-
(2010)
Biochem Pharmacol
, vol.80
, pp. 613-623
-
-
Yoshida, T.1
Zhang, G.2
Haura, E.B.3
-
65
-
-
72949092456
-
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
-
Zhou W, Ercan D, Chen L, Yun CH, Li D, Capelletti M, Cortot AB, Chirieac L, Iacob RE, Padera R, Engen JR, Wong KK, Eck MJ, Gray NS, Janne PA (2009) Novel mutant-selective EGFR kinase inhibitors against EGFR T790M. Nature 462: 1070-1074
-
(2009)
Nature
, vol.462
, pp. 1070-1074
-
-
Zhou, W.1
Ercan, D.2
Chen, L.3
Yun, C.H.4
Li, D.5
Capelletti, M.6
Cortot, A.B.7
Chirieac, L.8
Iacob, R.E.9
Padera, R.10
Engen, J.R.11
Wong, K.K.12
Eck, M.J.13
Gray, N.S.14
Janne, P.A.15
|